Definitive Contract 75A50120C00154
Award Date
7/27/20
Potential Completion Date
2/28/23
Potential Value
$485K
Awardee
Esperovax Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Plymouth, MI 48170, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
20
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $749,549.00, was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Immunexpress Inc., a for-profit foreign-owned company. The contract is for the "ASSESSMENT & TRIAGE OF PATIENTS WITH ESCALATING SIGNS OF COVID-19 DISEASE USING A HOST RESPONSE TEST FOR SEPSIS" and is a definitive, firm-fixed-price contract with a period of performance ending on June 10, 2023. The contract award originated from a Broad...
Xequel Bio, Inc., doing business as FSR, was awarded a $749,999 firm fixed price definitive contract from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to support research under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Special Instructions 019 seeks host-directed therapeutic candidates to aid long-term outcomes from lung injury. Under the contract, FSR will pursue safety review of such...
This is a federal contract award made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), part of the U.S. Department of Health and Human Services (HHS), to Venatorx Pharmaceuticals Inc., a biopharmaceutical company specializing in the discovery and development of novel anti-infective therapeutics. The contract, valued at $147,481,537.00, does not have a set-aside designation and was awarded as a definitive, cost-sharing contract. The work under this contract focuses...
This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Luminex Corporation is valued at $642,450.00. The contract supports the development of Luminex's ARIES SARS-CoV-2 assay under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Special Instructions 019 revised the description for mitigating long-term effects of respiratory distress and updated submission deadlines...
This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Inflammatix, Inc., a small disadvantaged business. The $749,999 firm fixed-price contract supports research and development for the Triverity cartridge, a diagnostic tool focused on infection severity and sepsis detection, under Area of Interest #2 of ASPR's Easy Broad Agency Announcement. The...
Siemens Healthcare Diagnostics Inc. was awarded a definitive contract valued at six hundred two thousand two hundred seventy-five dollars by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to conduct research and development of an automated immunoassay to aid in mitigating the long-term effects of respiratory distress from COVID-19. The award was made under Special Instructions 019 to the department's Easy Broad Agency Announcement...
Bioaegis Therapeutics Inc. was awarded a $749,000 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop a safe and effective therapeutic to mitigate severe outcomes including mortality in patients with severe infection or sepsis of any etiology. This award was made under Special Instructions 019 to the department's Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought host-directed...
This federal contract award was issued by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Protein Sciences Corp, a for-profit manufacturer, under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The $357,198.29 Firm Fixed Price delivery order supports Protein Sciences' research, development, manufacturing, and testing of vaccine candidates, antigens,...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $688,863 firm-fixed price contract to Avaxzipen LIMITED, doing business as Enesi Pharma, for the evaluation of novel solid dose vaccines for use in a future pandemic influenza. This contract was awarded under the Pandemic and All Hazard Preparedness Act and Pandemic and All Hazard Preparedness Reauthorization Act, which authorizes the Office of Biomedical Advanced Research and...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $575,000 firm fixed price definitive contract to Current Health LIMITED of Great Britain, United Kingdom. The contract supports development of real-time digital biomarker algorithms to enable early detection and improved management of SARS-CoV-2/COVID-19 infection, as requested in Special Instructions 019 under the agency's Easy Broad Agency Announcement BAA-20-100-SOL-0002....